cible tensionnelle; diabète de type 2; hypertension; insuffisance coronaire; néphropathie; recommandations; coronary heart disease; guidelines; nephropathy; therapeutic target; type 2 diabetes
Résumé :
[fr] L'hypertension artérielle est fréquemment observée chez le patient diabétique de type 2 et aggrave le pronostic cardio-vasculaire et rénal. Abaisser la pression artérielle représente donc un objectif essentiel dans cette population. Cependant, les valeurs de pression systolique et diastolique à atteindre restent controversées et la cible doit sans doute être ajustée en fonction des caractéristiques individuelles du patient ("médecine personnalisée"). Cette vignette clinique résume les principaux arguments à propos du choix des cibles tensionnelles, en termes de rapport bénéfices/risques, selon que le patient diabétique présente un syndrome métabolique sans complications, une néphropathie ou une insuffisance coronaire.
Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques
Langue du document :
Français
Titre :
Vignette thérapeutique de l'étudiant. Quelles cibles tensionnelles viser chez un patient diabétique de type 2?
Titre traduit :
[en] Which blood pressure targets in patients with type 2 diabetes?
Date de publication/diffusion :
janvier 2012
Titre du périodique :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Maison d'édition :
Université de Liège. Revue Médicale de Liège, Liège, Belgique
Volume/Tome :
67
Pagination :
51-56
Peer reviewed :
Peer reviewed
Commentaire :
Arterial hypertension is commonly observed in patients with type 2 diabetes and aggravates cardiovascular and renal outcomes. Lowering blood pressure is thus a key objective in this population. However, systolic and diastolic blood pressure levels to be reached remain controversial and targets should probably be adjusted according to patient's individual characteristics ("personalized medicine"). This clinical case summarizes the main arguments for selecting blood pressure targets, as far as benefits/risks is concerned, in type 2 diabetic patients with a metabolic syndrome but without complications, with a nephropathy, or with coronary artery disease.
Krzesinski, J.M., Weekers, L., Hypertension et diabète (2005) Rev Med Liège, 60, pp. 572-577
Scheen, A.J., Van Gaal, L.F., Type 2 diabetes, in the heart of the metabolic syndrome: Plea for a global approach (2005) Revue Medicale de Liege, 60 (5-6), pp. 566-571
Ryden, L., Standl, E., Malgorzata, B., Van Den, B.G., Betteridge, J., De Boer, M.-J., Cosentino, F., Wood, D., Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) (2007) European Heart Journal, 28 (1), pp. 88-136. , DOI 10.1093/eurheartj/ehl260
Scheen, A.J., Patient coronarien avec co-morbidités: Intégrer indications et contre-indications dans le raisonnement pharmaco-thérapeutique (2010) Rev Med Liège, 65, pp. 476-481
Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R., Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies (2002) Lancet, 360 (9349), pp. 1903-1913. , DOI 10.1016/S0140-6736(02)11911-8
Weekers, L., Krzesinski, J.M., La néphropathie diabétique (2005) Rev Med Liège, 60, pp. 479-486
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Zanchetti, A., 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007) Journal of Hypertension, 25 (6), pp. 1105-1187. , DOI 10.1097/HJH.0b013e3281fc975a, PII 0000487220070600000001
Mancia, G., Laurent, S., Agabiti-Rosei, E., Reappraisal of European guidelines on hypertension management: A European Society of Hypertension task force document (2009) J Hypertens, 27, pp. 2121-2158
Cushman, W.C., Evans, G.W., Byington, R.P., Effects of intensive blood-pressure control in type 2 diabetes mellitus (2010) N Engl J Med, 362, pp. 1575-1585. , ACCORD Study Group
Rutter, M.K., Nesto, R.W., Blood pressure, lipids and glucose in type 2 diabetes: How low should we go? Re-discovering personalized care (2011) Eur Heart J, 32, pp. 2247-2255
Krzesinski, F., Krzesinski, J.M., Pourquoi et comment faire mesurer la pression artérielle par le patient (2009) Rev Med Liège, 64, pp. 204-208
Chen, G., McAlister, F.A., Walker, R.L., Cardiovascular outcomes in Framingham participants with diabetes: The importance of blood pressure (2011) Hypertension, 57, pp. 891-897
Mehler, P.S., Jeffers, B.W., Estacio, R., Schrier, R.W., Associations of hypertension and complications in non-insulin-dependent diabetes mellitus (1997) American Journal of Hypertension, 10 (2), pp. 152-161. , DOI 10.1016/S0895-7061(96)00344-5, PII S0895706196003445
Sehestedt, T., Jeppesen, J., Hansen, T.W., Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population (2009) J Hypertens, 27, pp. 2351-2357
Catapano, A.L., Reiner, Z., De Backer, G., ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) (2011) Atherosclerosis, 217 (SUPPL. 1), pp. S1-S44. , Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Holman, R.R., Paul, S.K., Bethel, M.A., Long-term follow-up after tight control of blood pressure in type 2 diabetes (2008) N Engl J Med, 359, pp. 1565-1576
Pohl, M.A., Blumenthal, S., Cordonnier, D.J., Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial : Clinical implications and limitations (2005) J Am Soc Nephrol, 16, pp. 3027-3037
Berl, T., Hunsicker, L.G., Lewis, J.B., Pfeffer, M.A., Porush, J.G., Rouleau, J.-L., Drury, P.L., Lewis, E.J., Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial (2005) Journal of the American Society of Nephrology, 16 (7), pp. 2170-2179. , DOI 10.1681/ASN.2004090763
Scheen, A.J., Krzesinski, J.M., ADVANCE: Improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes (2007) Revue Medicale de Liege, 62 (10), pp. 639-643
De Galan, B.E., Perkovic, V., Ninomiya, T., Lowering blood pressure reduces renal events in type 2 diabetes (2009) J Am Soc Nephrol, 20, pp. 883-892
Weber, M.A., Bakris, G.L., Jamerson, K., Cardiovascular events during differing hypertension therapies in patients with diabetes (2010) J Am Coll Cardiol, 29 (56), pp. 77-85. , ACCOMPLISH Investigators
Krzesinski, J.M., Scheen, A.J., L'etude ACCOMPLISH: Remise en question des choix médicamenteux chez les patients hypertendus systoliques à haut risque cardio-vasculaire (2009) Rev Med Liège, 64, pp. 103-108
Radermecker, R., Philips, J.C., Jandrain, B., Contrôle glycémique et morbi-mortalité cardio-vasculaire chez le patient diabétique de type 2. Résultats des études ACCORD, ADVANCE et VA-Diabetes (2008) Rev Med Liège, 63, pp. 511-518
Cooper-DeHoff, R.M., Gong, Y., Handberg, E.M., Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary heart disease (2010) JAMA, 304, pp. 61-68
Bangalore, S., Kumar, S., Lobach, I., Messerli, F.H., Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: Observations from traditional and bayesian random-effects meta-analyses of randomized trials (2011) Circulation, 123, pp. 2799-2810
Reboldi, G., Gentile, G., Angeli, F., Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: A meta-analysis in 73,913 patients (2011) J Hypertens, 29, pp. 1253-1269
Dorresteijn, J.A., Van Der Graaf, Y., Spiering, W., Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited (2012) Hypertension, 59, pp. 14-21
Redon, J., Mancia, G., Sleight, P., Safety and efficacy of low blood pressures among patients with diabetes subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) (2012) J Am Coll Cardiol, 59, pp. 74-83. , ONTARGET Investigators
Krzesinski, J.M., Inertie thérapeutique dans le domaine de l'hypertension artérielle. Pourquoi et comment combattre cette attitude (2010) Rev Med Liège, 65, pp. 273-277
Krzesinski, J.M., Krzesinski, F., Importance de la mauvaise adhésion au traitement antihypertenseur dans la population hypertendue: Comment l'améliorer? (2010) Rev Med Liège, 65, pp. 278-284
Krzesinski, J.M., La vignette thérapeutique de l'étudiant. Comment gérer une hypertension artérielle qui devient résistante? (2009) Rev Med Liège, 64, pp. 171-175
Scheen, A.J., Philips, J.-C., Krzesinski, J.M., Hypertension et diabète: À propos d'une association commune mais complexe (2012) Rev Med Liège, p. 67. , sous presse
